Florida Governor Ron Desantis and his wife are coming under increasing scrutiny over their apparent use of millions in public settlement funds to bankroll a critical anti-cannabis legalization campaign.
US cannabis industry revenues are set to grow just 3.2% in 2025, as price compression, difficult economic dynamics and an increasingly complex political landscape put the brakes on the sector.
Florida’s medical cannabis industry is set to almost double, dismantling the monopoly 28 companies have held since 2017 in one of the US’s largest markets.
US cannabis companies have endured a significant selloff in the days following the results of the election, seeing $2.6bn wiped off their collective market capitalization.
Cannabis stocks plunge on election results As the outcome of the US presidential election and numerous state-specific cannabis ballots dripped through yesterday, the markets reacted in tandem.
Beyond the presidential result, yesterday key cannabis reform votes took place across numerous states, poised to have a significant impact the US cannabis industry.
As the most consequential US election in recent history comes to close after a long and turbulent campaign, the dust is beginning to settle on the prospective outlook for cannabis under the new administration.
If approved by voters on Tuesday, new regulated adult-use marijuana markets in Florida and North Dakota – along with a medical cannabis market in Nebraska – could collectively produce $3 billion during the first full year of sales.
November is set to be a critical month for cannabis legalization efforts in the US, with four states placing key cannabis reforms on the ballot.
